Determinants of gait speed in COPD.
暂无分享,去创建一个
C. Karpman | N. LeBrasseur | Z. Depew | P. Novotny | R. Benzo | Roberto P Benzo | Craig Karpman | Zachary S DePew | Nathan K LeBrasseur | Paul J Novotny
[1] R. Charlton,et al. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. , 2013, Chest.
[2] S. Hurd,et al. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) – why and what? , 2012, The clinical respiratory journal.
[3] S. Ozalevli,et al. Gait speed as a functional capacity indicator in patients with chronic obstructive pulmonary disease , 2011, Annals of thoracic medicine.
[4] H. Magnussen,et al. Physical activity in patients with COPD , 2008, European Respiratory Journal.
[5] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[6] Susan E. Hardy,et al. Improvement in Usual Gait Speed Predicts Better Survival in Older Adults , 2007, Journal of the American Geriatrics Society.
[7] C. Karpman,et al. Measuring Gait Speed in the Out-Patient Clinic: Methodology and Feasibility , 2014, Respiratory Care.
[8] L. Tavazzi,et al. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? , 2001, European heart journal.
[9] Henrik Johansson,et al. Measuring walking speed in COPD: test-retest reliability of the 30-metre walk test and comparison with the 6-minute walk test. , 2011, Primary care respiratory journal : journal of the General Practice Airways Group.
[10] C. Karpman,et al. Correlations Between Gait Speed, 6-Minute Walk Distance, Physical Activity, and Self-Efficacy in Patients With Severe Chronic Lung Disease , 2013, Respiratory Care.
[11] J. Wain,et al. Preoperative predictors of operative morbidity and mortality in COPD patients undergoing bilateral lung volume reduction surgery. , 1997, Chest.
[12] Drawing impairment predicts mortality in severe COPD. , 2004 .
[13] L. Edwards,et al. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. , 2013, American journal of respiratory and critical care medicine.
[14] S. Studenski,et al. Gait speed and survival in older adults. , 2011, JAMA.
[15] M. Fujita,et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. , 2000, American journal of respiratory and critical care medicine.
[16] G. Fei,et al. The Evaluation of Cognitive Impairment and Relevant Factors in Patients with Chronic Obstructive Pulmonary Disease , 2012, Respiration.
[17] Paul Cullinan,et al. Reliability and validity of 4-metre gait speed in COPD , 2012, European Respiratory Journal.
[18] Anne B. Newman,et al. Gait Speed Predicts Decline in Attention and Psychomotor Speed in Older Adults: The Health Aging and Body Composition Study , 2007, Neuroepidemiology.
[19] L. Edwards,et al. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. , 2012, Journal of the American Medical Directors Association.
[20] L. Fajardo,et al. Screening for preclinical disease: test and disease characteristics. , 2002, AJR. American journal of roentgenology.
[21] F. D'Ovidio,et al. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.
[22] B. Löwe,et al. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). , 2005, Journal of psychosomatic research.
[23] L. Edwards,et al. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. , 2010, Respiratory medicine.
[24] S. Studenski,et al. Physical Performance Measures in the Clinical Setting , 2003, Journal of the American Geriatrics Society.
[25] S. Rubin,et al. Prognostic Value of Usual Gait Speed in Well‐Functioning Older People—Results from the Health, Aging and Body Composition Study , 2005, Journal of the American Geriatrics Society.
[26] B. Celli,et al. The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.
[27] G. Ostir,et al. Assessing gait speed in acutely ill older patients admitted to an acute care for elders hospital unit. , 2012, Archives of internal medicine.
[28] Olaf Holz,et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. , 2011, Chest.
[29] J. Buckner,et al. Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. , 2007, Journal of pain and symptom management.
[30] S. Studenski,et al. Contributions of cognitive function to straight- and curved-path walking in older adults. , 2012, Archives of physical medicine and rehabilitation.
[31] Ciro Casanova,et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[32] S. Fritz,et al. White paper: "walking speed: the sixth vital sign". , 2009, Journal of geriatric physical therapy.
[33] Gregory T. Smith,et al. Using Self-Report Assessment Methods to Explore Facets of Mindfulness , 2006, Assessment.
[34] M. Tsukino,et al. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[35] M. Inzitari,et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force , 2009, The journal of nutrition, health & aging.
[36] P. Schnohr,et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study , 2006, Thorax.
[37] Tamara B Harris,et al. Daily activity energy expenditure and mortality among older adults. , 2006, JAMA.
[38] F. Martinez,et al. Factors to inform clinicians about the end of life in severe chronic obstructive pulmonary disease. , 2013, Journal of pain and symptom management.
[39] P. Paggiaro,et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.
[40] P. Jones,et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.
[41] M. Montero‐Odasso,et al. Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[42] S. Aaron,et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. , 2002, Chest.
[43] Lewis H Kuller,et al. Association Between Lower Digit Symbol Substitution Test Score and Slower Gait and Greater Risk of Mortality and of Developing Incident Disability in Well‐Functioning Older Adults , 2008, Journal of the American Geriatrics Society.